391 related articles for article (PubMed ID: 25736469)
1. Clinical proteomics and breast cancer.
Zeidan BA; Townsend PA; Garbis SD; Copson E; Cutress RI
Surgeon; 2015 Oct; 13(5):271-8. PubMed ID: 25736469
[TBL] [Abstract][Full Text] [Related]
2. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
3. [Towards a better knowledge of breast cancer physiopathology: the proteomics approach].
Hamrita B; Ben Nasr H; Hammann P; Kuhn L; Ben Anes A; Dimassi S; Chaieb A; Khairi H; Chahed K
Ann Biol Clin (Paris); 2012 Oct; 70(5):553-65. PubMed ID: 23047902
[TBL] [Abstract][Full Text] [Related]
4. SELDI-TOF-MS proteomics of breast cancer.
Clarke CH; Buckley JA; Fung ET
Clin Chem Lab Med; 2005; 43(12):1314-20. PubMed ID: 16309366
[TBL] [Abstract][Full Text] [Related]
5. Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery.
Bertucci F; Goncalves A
Future Oncol; 2008 Apr; 4(2):271-87. PubMed ID: 18407739
[TBL] [Abstract][Full Text] [Related]
6. New horizon for breast cancer biomarker discoveries: What might the liquid biopsy of nipple aspirate fluid hold?
Mannello F
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28627779
[TBL] [Abstract][Full Text] [Related]
7. Proteomics in cancer research: Are we ready for clinical practice?
Maes E; Mertens I; Valkenborg D; Pauwels P; Rolfo C; Baggerman G
Crit Rev Oncol Hematol; 2015 Dec; 96(3):437-48. PubMed ID: 26277237
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer classification by proteomic technologies: current state of knowledge.
Lam SW; Jimenez CR; Boven E
Cancer Treat Rev; 2014 Feb; 40(1):129-38. PubMed ID: 23891266
[TBL] [Abstract][Full Text] [Related]
9. Tissue culture-based breast cancer biomarker discovery platform.
Kulasingam V; Diamandis EP
Int J Cancer; 2008 Nov; 123(9):2007-12. PubMed ID: 18712711
[TBL] [Abstract][Full Text] [Related]
10. Proteomics of ovarian cancer: functional insights and clinical applications.
Elzek MA; Rodland KD
Cancer Metastasis Rev; 2015 Mar; 34(1):83-96. PubMed ID: 25736266
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer proteomics: a review for clinicians.
Galvão ER; Martins LM; Ibiapina JO; Andrade HM; Monte SJ
J Cancer Res Clin Oncol; 2011 Jun; 137(6):915-25. PubMed ID: 21465318
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of proteomics in breast cancer: state of the art and perspectives.
Goncalves A; Bertucci F
Med Princ Pract; 2011; 20(1):4-18. PubMed ID: 21160207
[TBL] [Abstract][Full Text] [Related]
13. Genomics and proteomics: emerging technologies in clinical cancer research.
Chung CH; Levy S; Chaurand P; Carbone DP
Crit Rev Oncol Hematol; 2007 Jan; 61(1):1-25. PubMed ID: 17015021
[TBL] [Abstract][Full Text] [Related]
14. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
Coleman O; Henry M; McVey G; Clynes M; Moriarty M; Meleady P
Expert Rev Proteomics; 2016; 13(4):383-94. PubMed ID: 26985644
[TBL] [Abstract][Full Text] [Related]
15. The use of proteomic technologies in breast cancer research.
Mazur MG; Pyatchanina TV
Exp Oncol; 2016 Sep; 38(3):146-57. PubMed ID: 27685521
[TBL] [Abstract][Full Text] [Related]
16. Proteomics: new technologies and clinical applications.
Latterich M; Abramovitz M; Leyland-Jones B
Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
[TBL] [Abstract][Full Text] [Related]
17. Using breast milk to assess breast cancer risk: the role of mass spectrometry-based proteomics.
Schneider SS; Aslebagh R; Ngounou Wetie AG; Sturgeon SR; Darie CC; Arcaro KF
Adv Exp Med Biol; 2014; 806():399-408. PubMed ID: 24952194
[TBL] [Abstract][Full Text] [Related]
18. Cancer proteomics: developments in technology, clinical use and commercialization.
Yeat NC; Lin C; Sager M; Lin J
Expert Rev Proteomics; 2015 Aug; 12(4):391-405. PubMed ID: 26145529
[TBL] [Abstract][Full Text] [Related]
19. Implications of functional proteomics in breast cancer.
Chae YK; Gonzalez-Angulo AM
Oncologist; 2014 Apr; 19(4):328-35. PubMed ID: 24664486
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.
Chung L; Baxter RC
Expert Rev Proteomics; 2012 Dec; 9(6):599-614. PubMed ID: 23256671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
